Formularies: Conceptual and Experimental Factors Related to Product Selection

Rucker T. D. : The top-selling drug products: How good are they? Am. J. Hosp. Pharm. 37:836, June 1980.

Sammons J. H. : New controls on physician prescribing are not needed. In: Controversies in therapeutics ( Lasagna L. , ed.). Philadelphia, W. B. Saunders Co., 1980. p. 543.

Rucker T. D. : Effective formulary development—which direction? Topics Hosp. Pharm. Manag. 1:34, May 1981.

ASHP statement on the pharmacy and therapeutics committee. Am. J. Hosp. Pharm. 35:814, July 1978.

Rolands T. F. Williams R. B. : How drugs attain formulary listing. Hospitals 49:89, Jan. 16, 1975.

Silverman M. Lee P. R. : Pills, profits, and politics. Berkeley, Univ. of California Press, 1974. p. 300.

Wolfe S. M. Coley C. M. : Pills that don't work. Washington, Health Research Group, 1980. pp. 1, 201–207.

ASHP statement of guiding principles on the operation of the hospital formulary system. Am. J. Hosp. Pharm. 21:40, Jan. 1964.

Linkewich J. A. Prevoznik S. J. : Guidelines on the operation of the pharmacy and therapeutics committee and formulary. Hosp. Pharm. 14:13, Jan. 1979.

Rucker T. D. : Effective formulary development—which direction? op. cit., p. 31.

Rucker T. D. : Restricted formulary drugs: An exploratory study. Hosp. Pharm. 17:246–253, May 1982.

ASHP guidelines for hospital formularies. Am. J. Hosp. Pharm. 35:326–328, Mar. 1978.

Davis N. M. : Formulary house cleaning. Hosp. Pharm. 14:2, Jan. 1979.

Rucker T. D. Morse M. L. : The medicaid drug program in Louisiana: Critique of the Hefner-Pracon study. Am. J. Hosp. Pharm. 37:1350–1353, Oct. 1980.

Rucker T. D. : Effective formulary development—which direction? op. cit., p. 39.

Rucker T. D. Visconti J. A. : How effective are drug formularies? A descriptive and normative study. Washington, ASHP Research & Education Foundation, 1979. p. 26.

World Health Organization: The selection of essential drugs. WHO Tech. Rep. Ser. No. 641, 1979. 44 pages.

Silverman M. Lee P. R. Lydecker M. : Pills and the public purse. Berkeley, Univ. of California Press, 1981. p. 102.

Rucker T. D. Visconti J. A. : op. cit., p. 109.

Quigley, M. A. and Brown, W. M.: A survey of selective administrative procedures in formulary maintenance. Hosp. Pharm. 16:374, July 1981.

ASHP statement on the pharmacy and therapeutics committee, op. cit.

ASHP guidelines for the scientific and therapeutic evaluation of drugs for hospital formularies. Am. J. Hosp. Pharm. 38:1043–1044, July 1981.

Rucker T. D. : Effective formulary development—which direction? op. cit., pp. 40–41.

Wertheimer A. I. , (ed.): Proceedings of the international conference on drug and pharmacy services reimbursement. DHEW Pub. No. (HRA) 77–3186, Nov. 2–5, 1976. p. 185.

Blum R. Herxheimer A. Stenzl C. Woodcock J. : Pharmaceuticals and health policy. London, Croom Helm, Ltd., 1981. pp. 67, 69, 160 and 262.

Rucker T. D. : The top-selling drug products: How good are they? op. cit., p. 835.

Quigley M. A. Brown W. M. : op. cit., p. 327.

Blum R. Kreitman K. : Factors affecting individual use of medicine. In: Pharmaceuticals and health policy, ( Blum R. , eds.), op. cit., p. 156.

Talley C. R. : Hospitals defend formulary decisions against industry attacks. Am. J. Hosp. Pharm. 35:1154–1155, Sept. 1978.

Rucker T. D. : Drug information: Findings from a major study of formularies. Drug. Inf. J. 13:42–43, Jan./June 1979.

Hassan W. E. : Hospital Pharmacy. Philadelphia, Lea & Febiger, 1981. p. 122.

Bunker J. P. Fowles J. Schaffarzick R. : Evaluation of medical-technological strategies. N. Engl. J. Med. 306:687–692, Mar. 18, 1982.

Drug regulation reform act of 1979. Title XVIII, H.R. 4258 and S. 1075, 1st Session, 96th Congress.

Rucker T. D. : Effective formulary development—which direction? op. cit., pp. 42–43.

Quigley M. A. Brown W. M. : op. cit., p. 373.

Rucker T. D. : Eight superior hospital formularies: A critique. Hosp. Pharm. in press.

World Health Organization, op. cit.

Heller W. M. , (ed.): The National Formulary and USP guide to select drugs. Rockville, MD., United State Pharmacopeial Convention, Inc., 1976. 295 pages.